Clinical Research Directory
Browse clinical research sites, groups, and studies.
American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry
Sponsor: University of Louisville
Summary
The purpose of this study is to create a registry to provide insight into treatment selection and treatment outcome of pancreatic IRE in order to develop an evidence base such that physicians can provide the best possible care to patients with pancreatic cancer requiring surgical interventions. The investigators seek a better understanding of the uses of ablation in the treatment of unresectable soft tissue pancreatic tumors and the limitations, concerns and complications that earlier users have.
Official title: AHPBA Pancreatic Irreversible Electroporation (IRE) Registry for Pancreatic Cancer
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
500
Start Date
2016-01
Completion Date
2030-01
Last Updated
2025-02-25
Healthy Volunteers
No
Conditions
Interventions
Registry
Locations (16)
University of Alabama Birmingham
Birmingham, Alabama, United States
University of California San Diego
San Diego, California, United States
University of Colorado
Denver, Colorado, United States
University of South Florida
Tampa, Florida, United States
Augusta University
Augusta, Georgia, United States
University of Louisville
Louisville, Kentucky, United States
Johns Hopkins Hospital
Baltimore, Maryland, United States
Atlantic Health
Millburn, New Jersey, United States
Northwell Health Cancer Institute
Lake Success, New York, United States
Gibbs Cancer Research, Spartanburg Regional Healthcare System
Spartanburg, South Carolina, United States
Methodist Digestive Institute
Dallas, Texas, United States
McGill University
Montreal, Quebec, Canada
Sanno Hospital
Tokyo, Japan, Japan
Centro Medico
Mexico City, Mexico
National Taiwan University
Taipei, Taiwan
Freeman Hospital
High Heaton, United Kingdom